BELLEVUE GROUP AG – Adaptive Biotechnologies Corporation Transaction History
BELLEVUE GROUP AG portfolio value:
$23.35M
portfolio value
BELLEVUE GROUP AG quarter portfolio value change:
-11.99%
quarter
Adaptive Biotechnologies Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -7.33% | -259.43K shares | -5.28M | $7.12 | 3.27M |
| Q2 2022 | share | Increase | +12.52% | 393.76K shares | -15.02M | $8.09 | 3.53M |
| Q1 2022 | share | Increase | +59.79% | 1.17M shares | -11.57M | $13.88 | 3.14M |
| Q4 2021 | share | Increase | +47.34% | 632.40K shares | 9.82M | $28.33 | 1.96M |
| Q3 2021 | share | Increase | +38.83% | 373.67K shares | 6.08M | $33.99 | 1.33M |
| Q2 2021 | share | Increase | 0.00% | 962.35K shares | 39.32M | $40.86 | 962.35K |